These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 16257545)

  • 21. New developments in vaccine research--unveiling the secret of vaccine adjuvants.
    de Veer M; Meeusen E
    Discov Med; 2011 Sep; 12(64):195-204. PubMed ID: 21955847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current developments in avian influenza vaccines, including safety of vaccinated birds as food.
    Swayne DE; Suarez DL
    Dev Biol (Basel); 2007; 130():123-33. PubMed ID: 18411943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mucosal immunization using recombinant plant-based oral vaccines.
    Streatfield SJ
    Methods; 2006 Feb; 38(2):150-7. PubMed ID: 16431131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Replacement, reduction and refinement alternatives to animal use in vaccine potency measurement.
    Hendriksen CF
    Expert Rev Vaccines; 2009 Mar; 8(3):313-22. PubMed ID: 19249973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccine process technology.
    Josefsberg JO; Buckland B
    Biotechnol Bioeng; 2012 Jun; 109(6):1443-60. PubMed ID: 22407777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccination as a control strategy against the coccidial parasites Eimeria, Toxoplasma and Neospora.
    Innes EA; Vermeulen AN
    Parasitology; 2006; 133 Suppl():S145-68. PubMed ID: 17274844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
    Jadhao SJ; Lee CW; Sylte M; Suarez DL
    Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A refined symptom-based approach to diagnose pulmonary tuberculosis in children.
    Marais BJ; Gie RP; Hesseling AC; Schaaf HS; Lombard C; Enarson DA; Beyers N
    Pediatrics; 2006 Nov; 118(5):e1350-9. PubMed ID: 17079536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potency assays for therapeutic live whole cell cancer vaccines.
    Petricciani J; Egan W; Vicari G; Furesz J; Schild G
    Biologicals; 2007 Apr; 35(2):107-13. PubMed ID: 16882459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.
    Perrie Y; Mohammed AR; Kirby DJ; McNeil SE; Bramwell VW
    Int J Pharm; 2008 Dec; 364(2):272-80. PubMed ID: 18555624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent applications of biotechnology to novel diagnostics for aquatic animals.
    Adams A; Thompson KD
    Rev Sci Tech; 2008 Apr; 27(1):197-209. PubMed ID: 18666488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulatory considerations for emergency use of non-USDA licensed vaccines in the United States.
    Hill RE; Foley PL; Carr MY; Elsken LA; Gatewood DM; Ludemann LR; Wilbur LA
    Dev Biol (Basel); 2003; 114():31-52. PubMed ID: 14677675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rationale and perspectives on the success of vaccination against bovine herpesvirus-1.
    van Drunen Littel-van den Hurk S
    Vet Microbiol; 2006 Mar; 113(3-4):275-82. PubMed ID: 16330163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A potential disruptive technology in vaccine development: gene-based vaccines and their application to infectious diseases.
    Kaslow DC
    Trans R Soc Trop Med Hyg; 2004 Oct; 98(10):593-601. PubMed ID: 15289096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New vaccine technologies.
    Wood DJ
    Dev Biol (Basel); 2002; 111():285-90. PubMed ID: 12678251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular approaches for safer and stronger vaccines.
    Del Giudice G; Rappuoli R
    Schweiz Med Wochenschr; 1999 Nov; 129(46):1744-8. PubMed ID: 10603647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A heat-stable oral polio vaccine -- waiting for a decision. CVI goal: vaccines that withstand heat.
    CVI Forum; 1995 Oct; (10):19-20. PubMed ID: 12290722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent developments in veterinary vaccinology.
    Shams H
    Vet J; 2005 Nov; 170(3):289-99. PubMed ID: 16266843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant vaccines for influenza virus.
    Tripp RA; Tompkins SM
    Curr Opin Investig Drugs; 2008 Aug; 9(8):836-45. PubMed ID: 18666031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bluetongue vaccines: the past, present and future.
    Bhanuprakash V; Indrani BK; Hosamani M; Balamurugan V; Singh RK
    Expert Rev Vaccines; 2009 Feb; 8(2):191-204. PubMed ID: 19196199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.